FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 02:25:13 2024-07-05 pm EDT | ||
| 10.06 EUR | -3.92% |
|
| Current month | +10.92% | ||
| 1 month | -12.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 10.06 | -3.92% |
| 24-07-04 | 10.47 | +1.36% |
| 24-07-03 | 10.33 | +11.19% |
| 24-07-02 | 9.29 | -0.75% |
| 24-07-01 | 9.36 | +3.20% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG3BLX |
| ISIN | DE000GG3BLX6 |
| Date issued | 2024-02-01 |
| Strike | 112.7 $ |
| Maturity | Unlimited |
| Parity | 2.56 : 1 |
| Emission price | 8.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.83 € |
|---|---|
| Lowest since issue | 6.88 € |
| Spread | 0.3 € |
| Spread % | 2.86% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
140.4
USD
Average target price
147.7
USD
Spread / Average Target
+5.17%
- Stock Market
- Certificates
- Certificat
